Could psilocybin change a young mother's cancer journey? Inside University of Colorado’s major psychedelic study

Kate Showalter's cancer journey led her to join a psilocybin study at the University of Colorado to cope with existential distress. The research, led by Jim Grigsby, PhD, and Stacy Fischer, MD, explores psilocybin’s potential in easing anxiety for terminal patients. Showalter, driven by her mother's past battle with cancer and her desire to live fully for her daughter, hopes this psychedelic therapy can bring her peace and presence during her challenging times.